# Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial

> **NCT03104335** · PHASE2 · WITHDRAWN · sponsor: **Peking University People's Hospital**

## Conditions studied

- Soft Tissue Sarcoma Adult
- Advanced Cancer

## Interventions

- **DRUG:** Apatinib

## Key facts

- **NCT ID:** NCT03104335
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-04-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2020-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not enough patients
- **Last updated:** 2020-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03104335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03104335, "Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03104335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*